🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: Millions of people each year sustain injuries, have tumors surg...
Status
Recruiting
Location
Johns Hopkins University School of Medicine
Start Date
2011-07-21
Trial ID
NCT01459107
The purpose of this study is to compare Reduced Intensity Conditioning prot...
Status
Completed
Location
Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza
Start Date
2005-03
Trial ID
NCT00354120
Treatments Being Tested
The investigators designed a compassionate basis phase II study for refract...
Status
Unknown
Location
Schering Peruana S.A.
Start Date
2005-07
Trial ID
NCT00157274
Treatments Being Tested
Study hypothesis: Simultaneous FMC-Alemtuzumab administration followed by A...
Status
Completed
Location
University Hospital Cologne
Start Date
2010-06
Trial ID
NCT01186640
Treatments Being Tested
Alemtuzumab is an antibody that reduces the strength of the immune system t...
Status
Recruiting
Location
Cincinnati Children's Hospital Medical Center
Start Date
2023-01-11
Trial ID
NCT05501756
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as fludarabine, and total...
Status
Terminated
Location
OHSU Knight Cancer Institute
Start Date
2003-05
Trial ID
NCT00416884
Treatments Being Tested
In this multicenter trial, we will investigate the use of fludarabine plus ...
Status
Completed
Location
Multiple Locations
Start Date
2002-01
Trial ID
NCT00193466
Treatments Being Tested
The development and progression of multiple sclerosis seem to be driven by ...
Status
Unknown
Location
Functional Imaging Unit, Department of Clinical Physiology, Nuclear medicine and PET, Glostrup Hospital
Start Date
2017-01-01
Trial ID
NCT03193086
Treatments Being Tested
Alemtuzumab is an anti CD52 monoclonal antibody. The CD52 antigen is presen...
Status
Completed
Location
Saint Antoine Hospital, Hematology Unit
Start Date
2006-10
Trial ID
NCT00773149
Treatments Being Tested
The MRI scan is one of the most important tools for diagnosing multiple scl...
Status
Completed
Location
Zuyderland MC
Start Date
2023-09-12
Trial ID
NCT05718947
Treatments Being Tested